argenx SE (ARGNF)
OTCMKTS · Delayed Price · Currency is USD
816.90
0.00 (0.00%)
At close: Jan 6, 2026
argenx SE Market Cap
argenx SE has a market cap or net worth of $49.07 billion as of January 7, 2026. Its market cap has increased by 29.41% in one year.
Market Cap
49.07B
Enterprise Value
45.20B
Revenue
3.68B
Ranking
n/a
PE Ratio
32.01
Stock Price
$816.90
Market Cap Chart
Since July 10, 2014, argenx SE's market cap has increased from 166.50M to 49.07B, an increase of 29,373.54%. That is a compound annual growth rate of 63.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 49.07B | -4.72% |
| Dec 31, 2025 | 51.51B | 37.35% |
| Dec 31, 2024 | 37.50B | 67.18% |
| Dec 29, 2023 | 22.43B | 8.92% |
| Dec 30, 2022 | 20.59B | 11.15% |
| Dec 31, 2021 | 18.53B | 32.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 773.31M |
| Glass House Brands | 719.98M |
| Elite Pharmaceuticals | 537.20M |
| Northwest Biotherapeutics | 397.78M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 342.98M |
| Silence Therapeutics | 290.49M |